No more silo mentality in an ivory tower. The university needs to share its knowledge with the community.
Start or finish your degree programme at Aarhus University.
Find your way around Aarhus University’s locations in Aarhus. Search by building numbers or addresses and see where the different units are located.
I received my PhD in Denmark, did my Post-Doc in Canada, and now work in as a senior scientist and advisor for the National Environmental Research Institute of Denmark, Aarhus University, where I also serve on the Academic Council. Prior to this I worked as Director for Environmental Safety for the Soap and Detergent Association (SDA) in Washington DC. where I managed the global hazard and screening level risk assessment of the largest OECD category of chemicals (> 30) and the highest annual tonnage (> 1.5 Mill. tons/yr) via the OECD HPV program. I have continued my professional education by following courses at Harvard, e.g. leadership, legal, and management training.
I have > 50 peer reviewed papers (including the most downloaded paper in Regulatory Toxicology and Pharmacology in 2004), four book chapters; I am a reviewer on 17 international journals, and have dozens of presentations and posters at international meetings, including e.g. invited presentations to: SOT Canada on emerging contaminants, NOAA workshop on emerging contaminants, an US interagency Presidential Task Force on risk assessment of pharmaceuticals, Health-Canada on risk assessment of pharmaceuticals and personal care products (PPCPs), National Academy of Sciences human health risk assessment of pharmaceuticals in drinking water.
I have served on a USEPA Scientific Advisory Board panel for review of the EPI Suite (Q)SAR models. I also served on the OECD ad hoc QSARs Expert Group representing the global Business and Industry Advisory Committee (BIAC), and I am appointed to a WHO expert committee on risk assessment of pharmaceuticals in drinking water.I have organized and chaired several international meeting sessions (including a highlighted session at SETAC in Baltimore 2005 on risk assessment and management of chemical categories under HPV, REACH, DSL). I initiated the SETAC Advisory Group on risk assessment of pharmaceuticals as well as the SETAC precautionary principle work group.
Publication: Commissioned - peer-review › Report
Publication: Research - peer-review › Journal article
Publication: Research - peer-review › Poster